Literature DB >> 9813550

Diabetes and coronary artery disease: time to stop taking the tablets?

M Connaughton, J Webber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9813550      PMCID： PMC1728790          DOI： 10.1136/hrt.80.2.108

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  2 in total

1.  Post-stenotic coronary blood flow at rest is not altered by therapeutic doses of the oral antidiabetic drug glibenclamide in patients with coronary artery disease.

Authors:  T Reffelmann; H G Klues; P Hanrath; E R Schwarz
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

2.  Sulfonylureas are not associated with increased mortality in diabetics treated with thrombolysis for acute myocardial infarction.

Authors:  A Halkin; A Roth; M Jonas; S Behar
Journal:  J Thromb Thrombolysis       Date:  2001-10       Impact factor: 2.300
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.